IntelGenx inks double deals to develop oral film psychedelics for psychiatric use

Drug delivery specialist IntelGenx has penned two deals to develop film-based, prescription psychedelics amid a surge of interest—and investment—from the biopharma industry.

Tapping its VersaFilm delivery platform, IntelGenx has teamed with Cybin Corp, a Canadian life sciences company focused on mushroom-based drugs and nutraceuticals, to explore developing an orally dissolving psilocybin strip for depression.